Yanchik Connealy Pamela's Form 4 filing
Pyxis Oncology, Inc. (PYXS) · filed Nov 27, 2024
- Accession no.
- 0000950170-24-131606
- Filed
- Nov 27, 2024
- Trade date
- Nov 26, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $174.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yanchik Connealy PamelaCIK 0001796310 | Officer (CFO & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Common Stock | PPurchaseAcquired | +5,450 | $2.00 | +$10,900 | 1,115,743 | Indirect | |
| Nov 26, 2024 | Common Stock | PPurchaseAcquired | +83,400 | $1.96 | +$163,464 | 1,199,143 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.